Stallion India

  • Market Cap: Micro Cap
  • Industry: Other Chemical products
  • ISIN: INE0RYC01010
  • NSEID: STALLION
  • BSEID: 544342
INR
128.90
0.9 (0.7%)
BSENSE

Mar 02

BSE+NSE Vol: 23.87 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

23.87 lacs (62.64%) Volume

Shareholding (Dec 2025)

FII

0.47%

Held by 13 FIIs

DII

0.68%

Held by 0 DIIs

Promoter

64.84%

Who are the top shareholders of the Stallion India?

06-Jun-2025

The top shareholder of Stallion India is Shazad Sheriar Rustomji, holding 67.88% of the shares. Other shareholders include 12 Foreign Institutional Investors with 3.32%, Geetu Yadav as the highest public shareholder at 4.16%, and individual investors holding 16.94%, with no pledged promoter holdings or mutual funds involved.

The top shareholders of Stallion India are primarily the promoters, with Shazad Sheriar Rustomji holding the largest share at 67.88%. In addition to the promoters, there are 12 Foreign Institutional Investors (FIIs) collectively holding 3.32% of the company. The highest public shareholder is Geetu Yadav, who owns 4.16%. Individual investors account for 16.94% of the total shareholding. Notably, there are no pledged promoter holdings and no mutual funds currently holding shares in the company.

View full answer

Has Stallion India declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Stallion India?

04-Jun-2025

Stallion India's peers include Solar Industries, Linde India, PCBL Chemical, Refex Industries, Prem. Explosives, DIC India, Keltech Energies, Beezaasan Exp., and Natl. Oxygen. Key insights show varying management risks, growth rates, and capital structures among these companies, with Refex Industries leading in 1-year returns at 270.26% and Linde India having the lowest at -15.03%.

Peers: The peers of Stallion India are Solar Industries, Linde India, PCBL Chemical, Refex Industries, Prem. Explosives, DIC India, Keltech Energies, Beezaasan Exp., and Natl. Oxygen.<BR><BR>Quality Snapshot: Excellent management risk is observed at Solar Industries, while Good management risk is found at Linde India and PCBL Chemical, and Average management risk is present at Refex Industries, Prem. Explosives, Stallion India, DIC India, Keltech Energies, and Beezaasan Exp. Excellent growth is seen at Solar Industries, PCBL Chemical, and Refex Industries, while Good growth is noted at Prem. Explosives and Beezaasan Exp., Average growth is found at Keltech Energies, and Below Average growth is present at Linde India and DIC India. Excellent capital structure is attributed to Solar Industries, Refex Industries, and Stallion India, while Average capital structure is seen at PCBL Chemical, and Good capital structure is noted at DIC India and Keltech Energies, with Below Average capital structure at Prem. Explosives and Natl. Oxygen.<BR><BR>Return Snapshot: Refex Industries has the highest 1-year return at 270.26%, while Linde India has the lowest at -15.03%. Stallion India's 1-year return is not available for comparison. Additionally, Linde India and DIC India have negative six-month returns.

View full answer

What does Stallion India do?

17-Jul-2025

Stallion India Fluorochemicals Ltd, a Micro Cap company established in 2002, operates in the Other Chemical products industry and reported net sales of 1,516 Cr and a net profit of 133 Cr for the quarter ending March 2025. The company has a market cap of INR 823 Cr and a P/E ratio of 25.00.

Overview: <BR>Stallion India Fluorochemicals Ltd operates in the Other Chemical products industry and is categorized as a Micro Cap company.<BR><BR>History: <BR>The company was incorporated in 2002 as a Private Limited Company in Mumbai and later converted to a Public Limited Company, with the name changed to Stallion India Fluorochemicals Limited on October 05, 2023. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1,516 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 133 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 823 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 25.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.24 <BR>Return on Equity: 10.75% <BR>Price to Book: 2.65 <BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

View full answer

How big is Stallion India?

24-Jul-2025

As of 24th July, Stallion India Fluorochemicals Ltd has a market capitalization of 929.00 Cr, with recent net sales of 304.28 Cr and a net profit of 23.91 Cr. The company's shareholder's funds are 117.96 Cr, and total assets amount to 202.40 Cr.

As of 24th July, Stallion India Fluorochemicals Ltd has a market capitalization of 929.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Stallion India reported Net Sales of 304.28 Cr and a Net Profit of 23.91 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 117.96 Cr and Total Assets of 202.40 Cr.

View full answer

When is the next results date for Stallion India?

01-Aug-2025

The next results date for Stallion India is 08 August 2025.

The next results date for Stallion India is scheduled for 08 August 2025.

View full answer

How has been the historical performance of Stallion India?

13-Oct-2025

Stallion India has shown significant growth over the past three years, with net sales increasing from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25, and profit after tax rising from 9.75 Cr to 32.33 Cr, reflecting strong operational efficiency and profitability. Total assets also grew substantially, indicating robust financial performance across key metrics.

Answer:<BR>The historical performance of Stallion India shows significant growth in various financial metrics over the past three years.<BR><BR>Breakdown:<BR>Stallion India's net sales increased from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25, indicating a strong upward trend. Total operating income followed suit, rising from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25. The company's total expenditure also grew, from 210.46 Cr in Mar'23 to 329.73 Cr in Mar'25, primarily driven by raw material costs, which surged from 195.58 Cr to 292.95 Cr during the same period. Operating profit (PBDIT) saw a substantial rise from 15.60 Cr in Mar'23 to 49.74 Cr in Mar'25, reflecting improved operational efficiency. Profit before tax increased from 12.97 Cr to 42.43 Cr, while profit after tax rose from 9.75 Cr to 32.33 Cr, showcasing a robust growth in profitability. The earnings per share (EPS) also improved significantly, from 1.77 in Mar'23 to 4.08 in Mar'25. On the balance sheet, total assets grew from 125.43 Cr in Mar'23 to 327.21 Cr in Mar'25, with total liabilities increasing from 125.43 Cr to 327.21 Cr as well. The cash flow from financing activities remained positive, contributing to a net cash inflow of 42.00 Cr in Mar'25, up from 15.00 Cr in Mar'24. Overall, Stallion India has demonstrated a strong financial performance with consistent growth across key metrics.

View full answer

Is Stallion India overvalued or undervalued?

27-Nov-2025

As of November 26, 2025, Stallion India is considered overvalued with a PE ratio of 45.93, an EV to EBITDA of 29.40, and a PEG ratio of 0.00, significantly higher than its peers and has underperformed against the Sensex with a 1-month return of -41.72%.

As of 26 November 2025, Stallion India has moved from a valuation grade of very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 45.93, an EV to EBITDA of 29.40, and a ROCE of 19.73%. <BR><BR>In comparison to its peers, Stallion India's PE ratio is significantly higher than Godrej Industries, which stands at 36.8, and Deepak Nitrite at 40.22. The PEG ratio for Stallion is 0.00, indicating no growth expectations priced into the stock, which is concerning given its high valuation. Additionally, Stallion India has underperformed against the Sensex, with a 1-month return of -41.72% compared to the Sensex's 1.66% return, further reinforcing the notion that the stock may be overvalued.

View full answer

Which are the latest news on Stallion India?

02-Mar-2026
No latest news for Stallion India found.

Should I buy, sell or hold Stallion India Fluorochemicals Ltd?

02-Mar-2026

Why is Stallion India Fluorochemicals Ltd falling/rising?

03-Mar-2026

As of 02-Mar, Stallion India Fluorochemicals Ltd's stock price is rising to 128.90, driven by recent gains and increased investor participation, despite a challenging year-to-date performance. The company has shown strong long-term growth with significant profit increases, although concerns about valuation and reduced promoter confidence may affect sentiment.

As of 02-Mar, Stallion India Fluorochemicals Ltd's stock price is rising, currently at 128.90, with a change of 0.9 (0.7%) upwards. This increase can be attributed to several factors. The stock has outperformed its sector by 1.4% today and has shown a consecutive gain over the last two days, rising by 5.4% during this period. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 67.17% against the 5-day average, indicating heightened interest in the stock.<BR><BR>Despite a challenging year-to-date performance, where the stock has fallen by 35.63%, it has demonstrated strong long-term growth, with an impressive annual operating profit growth rate of 85.69%. The company reported positive financial results for the latest six months, with a profit after tax of Rs 22.55 crore, reflecting a growth of 112.14%, and net sales of Rs 210.21 crore, which grew by 37.65%. Furthermore, the stock has generated a remarkable return of 133.48% over the past year, significantly outperforming the market benchmark.<BR><BR>However, it is important to note that there are concerns regarding the stock's valuation, as indicated by a price-to-book value of 4.7 and a return on equity of 10.2. Additionally, a decrease in promoter confidence, with a reduction of 3.06% in their stake, may also influence investor sentiment. Nonetheless, the current upward movement in the stock price is primarily driven by recent gains, increased trading activity, and strong financial performance.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With ROE of 10.2, it has a Expensive valuation with a 4.7 Price to Book Value

  • Over the past year, while the stock has generated a return of 133.48%, its profits have risen by 109%
2

Reducing Promoter Confidence

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Other Chemical products

stock-summary
Market cap

INR 1,559 Cr (Micro Cap)

stock-summary
P/E

46.00

stock-summary
Industry P/E

39

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.26

stock-summary
Return on Equity

10.17%

stock-summary
Price to Book

4.68

Revenue and Profits:
Net Sales:
105 Cr
(Quarterly Results - Dec 2025)
Net Profit:
11 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.85%
0%
-12.85%
6 Months
-6.82%
0%
-6.82%
1 Year
133.48%
0%
133.48%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Stallion India for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Press Release / Media Release

23-Feb-2026 | Source : BSE

As per attachment.

Announcement under Regulation 30 (LODR)-Newspaper Publication

18-Feb-2026 | Source : BSE

Submission of copy of Newspaper Advertisement for opening of Right Issue of the Company.

Announcement under Regulation 30 (LODR)-Investor Presentation

17-Feb-2026 | Source : BSE

Submission of copy of Newspaper Advertisement for opening of Right Issue of the Company.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Stallion India Fluorochemicals Ltd has announced 19:41 rights issue, ex-date: 11 Feb 26

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
29.40%
EBIT Growth (5y)
85.69%
EBIT to Interest (avg)
8.48
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
1.21
Tax Ratio
23.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.15%
ROCE (avg)
20.06%
ROE (avg)
10.75%

Valuation key factors

Factor
Value
P/E Ratio
46
Industry P/E
39
Price to Book Value
4.71
EV to EBIT
30.38
EV to EBITDA
29.64
EV to Capital Employed
6.00
EV to Sales
3.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
19.73%
ROE (Latest)
10.17%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 13 FIIs (0.47%)

Promoter with highest holding

Shazad Sheriar Rustomji (64.81%)

Highest Public shareholder

Geetu Yadav (4.16%)

Individual Investors Holdings

26.57%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -0.86% vs -4.44% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -2.54% vs 10.23% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "104.65",
          "val2": "105.56",
          "chgp": "-0.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.34",
          "val2": "15.57",
          "chgp": "-14.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.06",
          "val2": "0.23",
          "chgp": "-73.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "11.13",
          "val2": "11.42",
          "chgp": "-2.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.75%",
          "val2": "14.75%",
          "chgp": "-2.00%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 53.51% vs 51.75% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 31.44% vs 204.60% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "216.04",
          "val2": "140.73",
          "chgp": "53.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.88",
          "val2": "24.74",
          "chgp": "20.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.45",
          "val2": "2.49",
          "chgp": "-81.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "21.78",
          "val2": "16.57",
          "chgp": "31.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.83%",
          "val2": "17.58%",
          "chgp": "-3.75%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 41.97% vs 14.43% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 24.90% vs 59.02% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "320.69",
          "val2": "225.88",
          "chgp": "41.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43.22",
          "val2": "39.05",
          "chgp": "10.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.51",
          "val2": "4.22",
          "chgp": "-87.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "32.91",
          "val2": "26.35",
          "chgp": "24.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.48%",
          "val2": "17.29%",
          "chgp": "-3.81%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 61.83% vs 3.43% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 108.99% vs 58.67% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "377.45",
          "val2": "233.24",
          "chgp": "61.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "47.72",
          "val2": "23.86",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.15",
          "val2": "4.15",
          "chgp": "48.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "32.33",
          "val2": "15.47",
          "chgp": "108.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.64%",
          "val2": "10.23%",
          "chgp": "2.41%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
104.65
105.56
-0.86%
Operating Profit (PBDIT) excl Other Income
13.34
15.57
-14.32%
Interest
0.06
0.23
-73.91%
Exceptional Items
0.00
0.00
Standalone Net Profit
11.13
11.42
-2.54%
Operating Profit Margin (Excl OI)
12.75%
14.75%
-2.00%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -0.86% vs -4.44% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -2.54% vs 10.23% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
216.04
140.73
53.51%
Operating Profit (PBDIT) excl Other Income
29.88
24.74
20.78%
Interest
0.45
2.49
-81.93%
Exceptional Items
0.00
0.00
Standalone Net Profit
21.78
16.57
31.44%
Operating Profit Margin (Excl OI)
13.83%
17.58%
-3.75%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 53.51% vs 51.75% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 31.44% vs 204.60% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
320.69
225.88
41.97%
Operating Profit (PBDIT) excl Other Income
43.22
39.05
10.68%
Interest
0.51
4.22
-87.91%
Exceptional Items
0.00
0.00
Standalone Net Profit
32.91
26.35
24.90%
Operating Profit Margin (Excl OI)
13.48%
17.29%
-3.81%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 41.97% vs 14.43% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 24.90% vs 59.02% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
377.45
233.24
61.83%
Operating Profit (PBDIT) excl Other Income
47.72
23.86
100.00%
Interest
6.15
4.15
48.19%
Exceptional Items
0.00
0.00
Standalone Net Profit
32.33
15.47
108.99%
Operating Profit Margin (Excl OI)
12.64%
10.23%
2.41%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 61.83% vs 3.43% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 108.99% vs 58.67% in Mar 2024

stock-summaryCompany CV
About Stallion India Fluorochemicals Ltd stock-summary
stock-summary
Stallion India Fluorochemicals Ltd
Micro Cap
Other Chemical products
Stallion India Fluorochemicals Limited was incorporated as Private Limited Company as 'Stallion India Fluorochemicals Private Limited' in Mumbai on September 5, 2002, with the RoC. The status of the Company got converted to Public Limited and name of the Company was changed to Stallion India Fluorochemicals Limited through a fresh Certificate of Incorporation dated October 5, 2023 issued by the RoC. The Company issued 2,21,61,396 equity shares of face value of Rs 10 each, by raising Rs 199.
Company Coordinates stock-summary
Icon
No Company Details Available